Pfizer Ibrance Hopes Dashed In Early-Stage Breast Cancer

 
• By Joseph Haas
  
New York, July 19, 2016: Corporate lettering on the exterior of the Pfizer headquarters in Manhattan.
With a second failed study, Pfizer's hopes for Ibrance in early breast cancer crash
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D